These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 17706778)

  • 21. Feline immunodeficiency virus infection--causative agent of an acquired immunodeficiency syndrome in cats.
    Hartmann K
    Eur J Med Res; 1996 Nov; 1(12):547-50. PubMed ID: 9438159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of feline immunodeficiency virus ORF-A mutants as candidate attenuated vaccine.
    Pistello M; Bonci F; Isola P; Mazzetti P; Merico A; Zaccaro L; Matteucci D; Bendinelli M
    Virology; 2005 Feb; 332(2):676-90. PubMed ID: 15680433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel approaches to vaccination against the feline immunodeficiency virus.
    Pistello M; Conti F; Vannucci L; Freer G
    Vet Immunol Immunopathol; 2010 Mar; 134(1-2):48-53. PubMed ID: 19896725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon.
    Gupta S; Leutenegger CM; Dean GA; Steckbeck JD; Cole KS; Sparger EE
    J Virol; 2007 Jan; 81(2):465-73. PubMed ID: 17079309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of protection against feline immunodeficiency virus infection among domestic cats in New Zealand vaccinated with the Fel-O-Vax® FIV vaccine.
    Stickney A; Ghosh S; Cave NJ; Dunowska M
    Vet Microbiol; 2020 Nov; 250():108865. PubMed ID: 33045631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feline immunodeficiency virus diagnosis after vaccination.
    Andersen PR; Tyrrell P
    Anim Health Res Rev; 2004 Dec; 5(2):327-30. PubMed ID: 15984349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequence variation of the feline immunodeficiency virus genome and its clinical relevance.
    Stickney AL; Dunowska M; Cave NJ
    Vet Rec; 2013 Jun; 172(23):607-14. PubMed ID: 23749359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral activity in vitro of Urtica dioica L., Parietaria diffusa M. et K. and Sambucus nigra L.
    Uncini Manganelli RE; Zaccaro L; Tomei PE
    J Ethnopharmacol; 2005 Apr; 98(3):323-7. PubMed ID: 15814267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination of cats against feline immunodeficiency virus (FIV): a matter of challenge.
    Hesselink W; Sondermeijer P; Pouwels H; Verblakt E; Dhore C
    Vet Microbiol; 1999 Sep; 69(1-2):109-10. PubMed ID: 10515278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccine.
    Bęczkowski PM; Harris M; Techakriengkrai N; Beatty JA; Willett BJ; Hosie MJ
    Vaccine; 2015 Feb; 33(8):977-84. PubMed ID: 25613718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of a feline immunodeficiency virus vaccine.
    Huang C; Conlee D; Loop J; Champ D; Gill M; Chu HJ
    Anim Health Res Rev; 2004 Dec; 5(2):295-300. PubMed ID: 15984343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccine protection against feline immunodeficiency virus: setting the challenge.
    Hosie MJ; Beatty JA
    Aust Vet J; 2007; 85(1-2):5-12; quiz 85. PubMed ID: 17300445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of ISCOM-adjuvanted subunit vaccines containing recombinant feline immunodeficiency virus Rev, OrfA and envelope protein in cats.
    Huisman W; Schrauwen EJ; Pas SD; van Amerongen G; Rimmelzwaan GF; Osterhaus AD
    Vaccine; 2008 May; 26(21):2553-61. PubMed ID: 18430494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 p24 vaccine protects cats against feline immunodeficiency virus infection.
    Coleman JK; Pu R; Martin M; Sato E; Yamamoto JK
    AIDS; 2005 Sep; 19(14):1457-66. PubMed ID: 16135898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feline immunodeficiency virus model for designing HIV/AIDS vaccines.
    Yamamoto JK; Sanou MP; Abbott JR; Coleman JK
    Curr HIV Res; 2010 Jan; 8(1):14-25. PubMed ID: 20210778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An initial examination of the potential role of T-cell immunity in protection against feline immunodeficiency virus (FIV) infection.
    Aranyos AM; Roff SR; Pu R; Owen JL; Coleman JK; Yamamoto JK
    Vaccine; 2016 Mar; 34(12):1480-8. PubMed ID: 26802606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo infection of ramified microglia from adult cat central nervous system by feline immunodeficiency virus.
    Hein A; Martin JP; Koehren F; Bingen A; Dörries R
    Virology; 2000 Mar; 268(2):420-9. PubMed ID: 10704350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New vaccine to fight feline FIV.
    Aust Vet J; 2004 Dec; 82(12):730. PubMed ID: 15648930
    [No Abstract]   [Full Text] [Related]  

  • 39. Vaccination with fixed feline immunodeficiency virus (FIV) infected cells: protection, breakthrough and specificity of response.
    Bishop SA; Stokes CR; Gruffydd-Jones TJ; Whiting CV; Humphries JE; Osborne R; Papanastasopoulou M; Harbour DA
    Vaccine; 1996 Sep; 14(13):1243-50. PubMed ID: 8961513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perspectives on FIV vaccine development.
    Elyar JS; Tellier MC; Soos JM; Yamamoto JK
    Vaccine; 1997; 15(12-13):1437-44. PubMed ID: 9302758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.